These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20670190)

  • 1. Gene therapy and angiogenesis in patients with coronary artery disease.
    Kastrup J
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1127-38. PubMed ID: 20670190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
    Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
    Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis.
    Grossman JD; Grossman W
    Rev Cardiovasc Med; 2002; 3(3):138-44. PubMed ID: 12439438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
    Jones WS; Annex BH
    Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis for the treatment of inoperable coronary disease: the future.
    Sellke FW; Laham R; Suuronen EJ; Ruel M
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):184-8. PubMed ID: 16959748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis: a biologic bypass.
    Syed IS; Sanborn TA; Rosengart TK
    Cardiology; 2004; 101(1-3):131-43. PubMed ID: 14988635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
    Khan TA; Sellke FW; Laham RJ
    Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
    Sun L; Bai Y; Du G
    Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balancing act: therapeutic approaches for the modulation of angiogenesis.
    Springer ML
    Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic angiogenesis for coronary artery disease. Contemporary results and perspectives].
    Dudek D; Heba G; Rzeszutko Ł; Dubiel JS
    Przegl Lek; 2001; 58(11):1000-3. PubMed ID: 11987827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).
    Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S
    Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease.
    Fuchs S; Dib N; Cohen BM; Okubagzi P; Diethrich EB; Campbell A; Macko J; Kessler PD; Rasmussen HS; Epstein SE; Kornowski R
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):372-8. PubMed ID: 16892433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy.
    Nikol S; Huehns TY
    J Invasive Cardiol; 2001 Apr; 13(4):333-8. PubMed ID: 11287726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
    Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
    Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative therapeutic strategies for patients with severe end-stage coronary artery disease not amenable to conventional revascularization.
    Almeda FQ; Parrillo JE; Klein LW
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):57-66. PubMed ID: 12929105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis (clinical trials).
    Laham R
    Can J Cardiol; 2001 May; 17 Suppl A():29A-32A. PubMed ID: 11381293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials.
    Ylä-Herttuala S; Markkanen JE; Rissanen TT
    Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of L-arginine on fibroblast growth factor 2-induced angiogenesis in a model of endothelial dysfunction.
    Voisine P; Li J; Bianchi C; Khan TA; Ruel M; Xu SH; Feng J; Rosinberg A; Malik T; Nakai Y; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I202-7. PubMed ID: 16159817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.